therapeutics

His comment calling vaccines and therapeutics the “jackpot” at a July 17, 2020, virtual rally with Wisconsin voters was typical of his salesmanship.

“It could be good for... vaccine manufacturers, and also for people trying to identify therapeutics, particularly antibodies to get some insight early on into which mutations might arise even a year in the future.”

The findings, published in Nature Communications on June 18, 2024, will inspire a flurry of new studies and telomere-targeting therapeutics to treat age-related diseases.

"This approach not only bridges ancient practices with modern scientific methods but also minimizes the use of protein therapeutics, which carry risks of inducing abnormal tissue growth and cancerous formations," Gaharwar said.

Protein-based therapeutics have many virtues -- they can have more specific effects, with lower toxicity and diminished immune response -- but ease of delivery is not one of them.